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D-glyceraldehyde-3-phosphate dehydrogenase’ 
(GAPD) is composed of 4 identical subunits [ 1,2] 
and it binds and also crystallizes with 3.5 to 4 moles 
NAD per mole of enzyme [3-61. Several authors 
have found that only two moles of firmly bound NAD 
per mole of GAPD were reducible [7-lo] or even 
onlyonemole [ll]. 
Our present results show that the amount of redu- 
cible firmly-bound NAD depends on the concentra- 
tion of GAPD, when measured with D-glyceraldehyde- 
3-phosphate in the presence of arsenate ions. 
Four times recrystallized GAPD isolated from swine 
muscle according to Elijdi and Sziirenyi [ 131 was dis- 
solved in 0.1 M glycine buffer pH 8.5. The concentra- 
tion of the protein was determined by measuring the 
optical density at 280 nm. The amount of firmly 
bound NAD was 3.6 mole per mole of GAPD as de- 
termined from the change in absorbancy of the GAPD- 
NAD complex at 360 nm (Racker-band) after adding 
NAD to the GAPD solution (- 1Oj M). The molecu- 
lar weight was taken as 140,000 [ 141 . The molar ex- 
tinction coefficient of NADH at 340 mn is 6.22 X 103 
[ 151. D-glyceraldehyde-a-phosphate was prepared 
from fructose-l ,6diphosphate [ 161 and the conta- 
minating inorganic phosphate was removed as de- 
scribed earlier [ 171. In the assay medium D-glycer- 
aldehyde-3-phosphate was used in - 10m3 M concen- 
tration in the presence of 10” M arsenate ion. The 
measured values were corrected for the decrease in 
absorbancy due to the disappearance of the Racker- 
band that, in turn, was caused by the transformation 
of NAD in the GAPD-NAD charge-transfer complex 
into NADH *. In the fluorimetric determination of 
NADH another correction was made for the quench- 
ing effect of GAPD. The latter was determined inde- 
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pendently with NADH-solution, the concentration of 
which was measured enzymically. 
When the concentration of ,GAPD is relatively high 
(- lOA M) only about two moles of firmly bound 
NAD can be reduced, while at about 10e7 M GAPD 
the amount of reducible NAD equals the total amount 
of NAD firmly bound to the enzyme (fig. 1). In the 
absence of arsenate and phosphate, there is no differ- 
ence in the amount of reducible bound NAD; using 
the above GAPD concentration range, i.e. from lOaM 
to low7 M, about two moles of NAD per mole of 
enzyme only are reduced (fig. 1). The reduction of 
bound NAD molecules, both in the presence and ab- 
sence of arsenate, is complete in the first second. 
Keleti et al. [20] and Chance and Park [21] sug- 
gested that there are two different types of firmly 
bound NAD in GAPD. Listovsky et al. [22] conclud- 
ed from optical rotatory dispersion studies that the 
NAD binding sites are not equivalent. Vijlder and 
Slater [ 191 and Koshland and Neet [23] found that 
two out of the four firmly bound NAD molecules 
were bound strongly, one moderately and one rela- 
tively weakly. A similar difference between the bind- 
* The molar extinction coefficient of the Kacker band at 
360 nm is E = 9.6 X lo2 [ 18,191. The correction was cal- 
culated as follows. The number of reduced NAD molecules 
A&340 nm, measured) + aE(340 mn, correction) 
n= 
where A&340 nm, correction) = n[GAPD] 9.6 X lo2 (with- 
out taking into account the very little difference between 
the ~(340 nm) and ~(360 nm) of the Racker band). From this 
n= 
A&340 nm, measured) 
[GAPD] 5.26 X lo3 . 
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Fig. 1. Effect of GAPD concentration on the reducibility of 
fimly bound NAD. 
1: determination of the amount of reducible firmly bound 
NAD in the presence of arsenate. 0 spectrofluorimetrically 
(excitation at 335 nm, measurement at 470 nm); X spec- 
troscopically at 340 nm. 
2: the same as in 1 but determined without arsenate. 0 spec- 
trophotometrically at 340 nm; 0 spectrofluorimetiically 
(excitation at 335 nm, measurement at 470 nm). 
An Qpton PMQ II spectrophotofluorimeter and automatic 
recording was used. 
ing sites of NAD was observed by means of gel filtra- 
tion of the partially carbethoxylated enzyme. In this 
case two out of the four moles of firmly bound NAD 
can be removed from the protein [ 121. There is 
some parallelism between these data and our present 
findings which show that two moles of firmly bound 
NAD are reducible in the presence of arsenate in 
relatively high concentration of GAPD, i.e. - 10-5 M 
(the same protein concentration was used by the 
authors who found also only two moles of firmly 
bound NAD to be reducible in GAPD [7-91) or in 
the absence of arsenate or phosphate independent of 
GAPD concentration. However, in the presence of 
arsenate the total amount of bound NAD becomes 
reducible at low concentrations of CARD. 
Since the four subunits of GAPD are identical [24] 
the differences in the reducibility of the four firmly 
bound molecules of NAD may indicate an asymmet- 
rical association of the subunits (perhaps type cu.& 
as supposed by Malhotra and Bernhard [25] ) and/or 
a possible dissociation of GAPD into protomers dur- 
ing dilution as determined by Constantinides and Deal 
[26,27]. 
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